Zura Bio Ltd (ZURA) shareholders
Close on Nov 19, 2026Market cap $91.74MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| AI Biotechnology LLC Joint filing with Access Industries Holdings LLC (18.20%), Access Industries Management, LLC (18.20%) and 1 more | 19,699,071 | 18.20% | 13D (active) amendment | Feb 26, 2026 |
| Len Blavatnik Joint filing with AI Biotechnology LLC (19.90%), Access Industries Holdings LLC (19.90%) and 1 more | 14,326,090 | 19.90% | 13D (active) | May 21, 2025 |
| UGS Capital LLC Joint filing with Athanor Capital (15.70%) | 11,581,402 | 15.70% | 13D (active) | Jan 23, 2026 |
| Athanor Capital Joint filing with UGS Capital LLC (15.70%) | 11,581,402 | 15.70% | 13G (passive) | Dec 29, 2025 |
| Bong Y. Koh Joint filing with Venrock Healthcare Capital Partners III, L.P. (9.90%), VHCP Co-Investment Holdings III, LLC (9.90%) and 4 more | 9,816,384 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| Aaron Cowen Joint filing with Suvretta Capital Management, LLC (9.90%), Averill Master Fund, Ltd. (8.80%) | 9,524,263 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| Bong Y Koh Joint filing with Venrock Healthcare Capital Partners III, L.P. (9.90%), VHCP Co-Investment Holdings III, LLC (9.90%) and 4 more | 7,031,271 | 9.90% | 13G (passive) amendment | Mar 31, 2025 |
| VHCP Management EG, LLC Joint filing with Venrock Healthcare Capital Partners III, L.P. (9.90%), VHCP Co-Investment Holdings III, LLC (9.90%) and 4 more | 6,353,353 | 9.90% | 13G (passive) amendment | Jun 30, 2025 |
| JPMorgan Chase & Co. | 4,672,416 | 7.50% | 13G (passive) | Jun 30, 2025 |
| Access Industries Holdings LLC Joint filing with AI Biotechnology LLC (9.90%), Access Industries Management, LLC (9.90%) and 1 more | 4,388,560 | 9.90% | 13G (passive) amendment | Dec 31, 2023 |
| Ms. Lillian Nordahl Joint filing with Great Point Partners, LLC (5.12%), Dr. Jeffrey R. Jay, M.D. (5.12%) | 3,170,194 | 5.12% | 13G (passive) | May 8, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ZURA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 9,443,001 | 9.80% | $55.71M | +376,000 | 1.02% |
| VR Adviser, LLC | 6,434,990 | 6.68% | $37.97M | – | 1.15% |
| Mpm Bioimpact LLC | 4,472,843 | 4.64% | $26.39M | New | 1.61% |
| JPMorgan Chase & Co | 4,354,715 | 4.52% | $24.52M | −104,136 | 0.00% |
| Great Point Partners LLC | 4,215,930 | 4.38% | $24.87M | – | 4.70% |
| Braidwell LP | 3,980,295 | 4.13% | $23.48M | −8,694 | 0.87% |
| Siren, L.L.C. | 3,734,866 | 3.88% | $22.04M | – | 0.45% |
| BlackRock, Inc. | 3,614,695 | 3.75% | $21.33M | +3,157,336 | 0.00% |
| Commodore Capital LP | 3,250,000 | 3.37% | $19.18M | – | 1.14% |
| Adage Capital Partners Gp, L.L.C. | 2,750,000 | 2.85% | $16.23M | – | 0.02% |
| Saturn V Capital Management LP | 2,101,119 | 2.18% | $12.40M | +1,361,159 | 1.78% |
| QVT Financial LP | 1,895,153 | 1.97% | $11.18M | +584,560 | 0.67% |
| ADAR1 Capital Management, LLC | 1,759,295 | 1.83% | $10.38M | +1,128,892 | 0.48% |
| Armistice Capital, LLC | 1,636,000 | 1.70% | $9.65M | +129,000 | 0.12% |
| Geode Capital Management, LLC | 1,584,209 | 1.64% | $9.35M | +1,056,518 | 0.00% |
| Affinity Asset Advisors, LLC | 1,464,303 | 1.52% | $8.64M | −1,100,000 | 0.39% |
| Stempoint Capital LP | 1,368,215 | 1.42% | $8.07M | −138,825 | 1.39% |
| Ikarian Capital, LLC | 1,218,492 | 1.26% | $7.19M | +25,000 | 0.77% |
| EcoR1 Capital, LLC | 1,179,715 | 1.22% | $6.96M | – | 0.34% |
| Vestal Point Capital, LP | 1,173,956 | 1.22% | $6.93M | +662,956 | 0.16% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 95 | 73M | 75.7% | 26 / 32 | 19 / 24 | 17M | 11M |
| Q1 2026 | 94 | 67M | 69.4% | 32 / 30 | 25 / 11 | 26M | 3M |
| Q4 2025 | 74 | 45M | 46.7% | 22 / 25 | 18 / 12 | 9M | 10M |
| Q3 2025 | 66 | 46M | 47.5% | 17 / 15 | 24 / 14 | 15M | 5M |
| Q2 2025 | 64 | 35M | 36.7% | 21 / 14 | 19 / 30 | 5M | 15M |
| Q1 2025 | 73 | 46M | 47.5% | 6 / 25 | 20 / 19 | 5M | 2M |
| Q4 2024 | 87 | 43M | 44.5% | 25 / 32 | 10 / 14 | 10M | 4M |
| Q3 2024 | 77 | 37M | 38.6% | 26 / 29 | 8 / 5 | 13M | 7M |
| Q2 2024 | 57 | 33M | 34.2% | 18 / 21 | 10 / 6 | 19M | 1M |
| Q1 2024 | 45 | 15M | 15.5% | 5 / 14 | 20 / 4 | 1M | 1M |
| Q4 2023 | 44 | 15M | 15.9% | 10 / 24 | 3 / 7 | 2M | 1M |
| Q3 2023 | 41 | 14M | 14.7% | 7 / 21 | 5 / 4 | 2M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
11 funds held ZURA in Q2 2026, 87% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ZURA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 747,352 | 0.78% | $4.41M | 0.00% | Jun 30, 2026 |
| ALPS Medical Breakthroughs ETF | 88,879 | 0.09% | $382.18K | 0.24% | May 31, 2026 |
| Nuveen Small Cap Blend Index Fund | 78,464 | 0.08% | $426.06K | 0.01% | Jul 31, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 47,740 | 0.05% | $281.67K | 0.00% | Jun 30, 2026 |
| Small Cap Index Fund | 30,476 | 0.03% | $179.81K | 0.01% | Jun 30, 2026 |
| Global X Russell 2000 ETF | 28,064 | 0.03% | $152.39K | 0.01% | Jul 31, 2026 |
| Avantis U.S. Small Cap Equity ETF | 25,846 | 0.03% | $111.14K | 0.00% | May 31, 2026 |
| Small Cap Index Trust | 12,595 | 0.01% | $74.31K | 0.01% | Jun 30, 2026 |
| SmallCap Growth Fund I | 5,086 | 0.01% | $27.62K | 0.00% | Jul 31, 2026 |
| Small Company Growth Portfolio | 4,487 | 0.00% | $26.47K | 0.10% | Jun 30, 2026 |
| Strategic Equity Allocation Trust | 2,748 | 0.00% | $16.21K | 0.00% | Jun 30, 2026 |
| Total Stock Market Index Trust | 1,608 | 0.00% | $9.49K | 0.00% | Jun 30, 2026 |
| Ultra Small Cap Profund | 759 | 0.00% | $4.12K | 0.01% | Jul 31, 2026 |
| Profund Vp Ultra Small Cap | 242 | 0.00% | $1.43K | 0.01% | Jun 30, 2026 |
| Profund Vp Small Cap | 158 | 0.00% | $932 | 0.01% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Sandeep Chidambar Kulkarni | Chief Executive Officer, Director | – | – | Apr 2, 2026 |
| Robert Lisicki | Chief Executive Officer, Director | – | – | Mar 3, 2025 |
| Marlyn Teresa Mathew | VP, Principal Acctg. Officer | 129,182 | 0.13% | Jun 22, 2026 |
| Gary Whale | Chief Technology Officer | – | – | Apr 2, 2026 |
| Eric J. Hyllengren | Chief Financial Officer | – | – | Apr 2, 2026 |
| Kim Davis | Chief Legal Officer | 493,881 | 0.51% | Apr 2, 2026 |
| Kiran Nistala | See Remarks | 3,195 | 0.00% | Apr 2, 2026 |
| Verender S. Badial | Chief Financial Officer | 517,519 | 0.54% | May 12, 2025 |
| Daniel J. Becker | Director | – | – | Jun 22, 2026 |
| Mark Eisner | Director | – | – | Jun 22, 2026 |
| Ajay Nirula | Director | – | – | Jun 22, 2026 |
| Jennifer Jarrett | Director | – | – | Jun 22, 2026 |
| Amit Munshi | Director | 777,384 | 0.81% | Jun 22, 2026 |
| Steven J. Schoch | Director | – | – | Jun 22, 2026 |
| Parvinder Thiara | Director | 0 | – | Jun 22, 2026 |
| van Amstel Arnout Ploos | Director | 120,000 | 0.12% | May 22, 2025 |
| Neil Murray Hamilton Graham | Director | – | – | May 22, 2025 |
| Someit Sidhu | Director | 5,203,715 | 5.40% | May 22, 2025 |
| Access Industries Management, Llc | 10% owner | – | – | Mar 2, 2026 |
| Biotechnology LLC AI | 10% owner | – | – | Mar 2, 2026 |
| Len Blavatnik | 10% owner | – | – | Mar 2, 2026 |
| Industries Holdings LLC Access | 10% owner | 6,552,725 | 6.80% | Mar 2, 2026 |
| Capital LLC UGS | 10% owner | – | – | Jan 2, 2026 |
| Capital Athanor | 10% owner | 11,581,402 | 12.02% | Jan 2, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Industries Holdings LLC Access 10% owner | Feb 26, 2026 | Buy | +2,000,000 | $6.25 | $12.50M | 6,552,725 |
| Parvinder Thiara Director | Nov 25, 2024 | Sale | −1,001,633 | $2.73 | $2.73M | 0 |
| Kim Davis Chief Legal Officer | Sep 16, 2024 | Award | +1,000 | – | – | 1,500 |
| Parvinder Thiara Director | Sep 11, 2024 | Sale | −3,800,000 | $2.70 | $10.26M | 1,001,633 |
| Someit Sidhu Director | Sep 4, 2024 | Other | −593,055 | – | – | 242,055 |
| Someit Sidhu Director | Sep 4, 2024 | Sale | −51,728 | $3.87 | $200.19K | 2,085,418 |
| Someit Sidhu Director | Aug 24, 2024 | Award | +721,971 | – | – | 2,807,389 |
| Someit Sidhu Director | Aug 24, 2024 | Award | +835,110 | – | – | 242,055 |
| Verender S. Badial Chief Financial Officer | Aug 23, 2024 | Award | +126,155 | – | – | 517,519 |
| Michael Howell See Remarks | May 18, 2024 | Tax withholding | −9,860 | $6.05 | $59.65K | 104,535 |
| van Amstel Arnout Ploos Director | May 17, 2024 | Buy | +80,000 | $6.20 | $496.00K | 100,000 |
| Kiran Nistala See Remarks | Apr 22, 2024 | Award | +3,195 | $3.13 | $10.00K | 3,195 |
| Michael Howell See Remarks | Apr 22, 2024 | Award | +7,987 | $3.13 | $25.00K | 7,987 |
| Amit Munshi Director | Apr 22, 2024 | Award | +159,744 | $3.13 | $500.00K | 777,384 |
| Someit Sidhu Director | Apr 22, 2024 | Award | +1,186,901 | $3.13 | $3.72M | 1,186,901 |
| Amit Munshi Director | Apr 22, 2024 | Buy | +159,744 | $3.13 | $500.00K | 777,384 |
| Michael Howell See Remarks | Apr 22, 2024 | Buy | +7,987 | $3.13 | $25.00K | 7,987 |
| Someit Sidhu Director | Apr 22, 2024 | Buy | +1,186,901 | $3.13 | $3.72M | 1,186,901 |
| Kiran Nistala Executive Vice President | Apr 22, 2024 | Buy | +3,195 | $3.13 | $10.00K | 3,195 |
| Parvinder Thiara Director, 10% owner | Dec 12, 2023 | Sale | −2,000,000 | $4.00 | $8.00M | 4,801,633 |
| Someit Sidhu Director | Nov 21, 2023 | Other | −351,000 | – | – | 242,055 |
| Kim Davis Chief Legal Officer | Oct 1, 2023 | Award | +500 | – | – | 500 |
| Someit Sidhu Director | Sep 28, 2023 | Other | −761,370 | – | – | 242,055 |
| Verender S. Badial Chief Financial Officer | Sep 28, 2023 | Other | +355,880 | – | – | 517,519 |
| Someit Sidhu Director | Sep 22, 2023 | Other | −200,484 | – | – | 2,807,389 |
| Verender S. Badial Chief Financial Officer | Sep 22, 2023 | Other | +35,484 | – | – | 517,519 |
| Amit Munshi Director | Jun 5, 2023 | Buy | +117,647 | $4.25 | $500.00K | 617,640 |
| Michael Howell See Remarks | May 18, 2023 | Award | +114,395 | – | – | 114,395 |
| Christopher Cabell CMO & Head of R&D | May 18, 2023 | Award | +162,060 | – | – | 162,060 |
| Kim Davis Chief Legal Officer | May 18, 2023 | Award | +492,381 | – | – | 492,381 |
| Jeffrey A. Altman 10% owner | Mar 20, 2023 | Other | −550,000 | $10.40 | $5.72M | 0 |
| Someit Sidhu Chief Executive Officer, Director, 10% owner | Mar 20, 2023 | Other | +2,337,630 | – | – | 2,337,630 |
| Someit Sidhu Chief Executive Officer, Director | Feb 10, 2023 | Other | −2,337,630 | – | – | 967,370 |
| JATT Ventures, L.P. 10% owner | Feb 10, 2023 | Other | −2,337,630 | – | – | 967,370 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Zura Bio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 18,272 shares on Sep 10, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Someit Sidhu Director | Aug 18, 2026 | 50,000 | $287.71K | Aug 18, 2026 | Stock Option Exercise |
| Someit Sidhu Director | Aug 17, 2026 | 27,000 | $151.34K | Aug 17, 2026 | Stock Option Exercise |
| Someit Sidhu Director | Aug 14, 2026 | 40,000 | $220.54K | Aug 14, 2026 | Stock Option Exercise |
| Someit Sidhu Director | Aug 13, 2026 | 51,000 | $287.04K | Aug 13, 2026 | Stock Option Exercise |
| Someit Sidhu Director | Sep 4, 2024 | 52,000 | $200.00K | Sep 4, 2024 | Merger |
See a number that looks wrong?